Citations 35
Serum Neurofilament Light Chain Levels (sNfL) Correlate Best with Attack-related Disability in Neuromyelitis Optica (4105)
Atkas, O., Hartung, HP, Smith, Michael , Rees, William A. , Marignier, Romain , Wingerchuk, Dean M. , Green, A., Drappa, Jörn , Barron, Gerard, Madani, S. , She, Dewei, Cimbora, D., Ratchford, John N. , Katz, Eliezer , Fujihara, Kazuo , Paul, Friedemann , Bennett, Jeffrey L. , Kim, H.J., Weinshenker, Brian G. , Pittock, Sean J. , Cutter, Gary , Mealy, Maureen A. , Madani, S., Wang, Lei , Cimbora, Daniel , Cree, Bruce
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension (3998)
Kim, H. J., Pittock, Sean J, Wingerchuk, Dean M. , Marignier, Romain , Green, A., Aktaş, Orhan , Hartung, HP, Lublin, Fred , Drappa, Jörn , Barron, Gerard, Madani, S. , She, Dewei, Cimbora, D., Rees, William A. , Ratchford, John N. , Katz, Eliezer , Cree, Bruce , Bennett, Jeffrey L. , Weinshenker, Brian G. , Pittock, Sean J. , Fujihara, Kazuo , Paul, Friedemann , Cutter, Gary , Mealy, Maureen A. , Madani, S., Cimbora, Daniel
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Efficacy and Safety of Eculizumab in Patients with Neuromyelitis Optica Spectrum Disorder Previously Treated with Rituximab: Findings from the Phase 3 PREVENT Study (1788)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Pace, Amy , Yountz, Marcus, Lawson, Diane, Meyer, Eva-Laudon , Wingerchuk, Dean M. , Levy, Michael , Berthele, Achim , Fujihara, Kazuo , Nakashima, Ichiro , Oreja‐Guevara, Celia , Pittock, Sean J. , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study (1780)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Pace, Amy, Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Impact of Eculizumab on Health Outcomes in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings from the PREVENT Study (1765)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Shang, Shulian, Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Berthele, Achim , Pittock, Sean J. , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Impact of Eculizumab on Disability Worsening and Quality of Life in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Results from the Phase 3 PREVENT Study (1658)
Kim, Ho Jin , Terzi, Murat , Wang, Kaichen , Shang, Shulian, Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494)
Wingerchuk, Dean M. , Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Allen, Kerstin , Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study (1299)
Kim, Ho Jin , Terzi, Murat , Wang, Kaichen , Pace, Amy , Yountz, Marcus, Miller, Larisa , Tanvir, Imran, Armstrong, Róisín, Wingerchuk, Dean M. , Fujihara, Kazuo , Berthele, Achim , Levy, Michael , Nakashima, Ichiro , Oreja‐Guevara, Celia , Palace, Jacqueline , Pittock, Sean J. , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
SAkuraBONSAI: A Prospective, Open-label Study of Satralizumab Investigating Novel Imaging, Biomarker, and Clinical Outcomes in Patients with Aquaporin-4-IgG-seropositive (P15.AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P15-1.002)
Marignier, Romain , Sergott, Robert C. , Anania, Veronica G. , Buffels, Régine, Künzel, Thomas, Lennon‐Chrimes, Siân , Traboulsee, Anthony , Fujihara, Kazuo , Kim, Ho Jin, O’Connor, Kevin C. , Wiendl, Heinz , Wuerfel, Jens , Zamvil, Scott S. , Pittock, Sean J. , Künzel, Thomas, Bennett, Jeffrey L.
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
Indirect Comparison Analysis of FDA-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder (P15-1.007)
Wingerchuk, Dean M. , Kielhorn, Adrian , Royston, Minying , Tanvir, Imran, Zhang, Ina, Pittock, Sean J. , Levy, Michael , Fujihara, Kazuo , Nakashima, Ichiro , Paul, Friedemann
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available